Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes
Systemically administered glucocorticoids constitute an essential part of the immunosuppressive regimen for transplant recipients, yet their known risks of causing hyperglycemia or posttransplant diabetes require close monitoring and minimisation of use, when possible, to prevent detrimental effects...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2023/3648178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549782246129664 |
|---|---|
| author | Simon Bøtker Henrik Birn Lara Aygen Øzbay |
| author_facet | Simon Bøtker Henrik Birn Lara Aygen Øzbay |
| author_sort | Simon Bøtker |
| collection | DOAJ |
| description | Systemically administered glucocorticoids constitute an essential part of the immunosuppressive regimen for transplant recipients, yet their known risks of causing hyperglycemia or posttransplant diabetes require close monitoring and minimisation of use, when possible, to prevent detrimental effects on patient morbidity and graft survival. Topical glucocorticoids, on the other hand, are rarely considered to affect glucose metabolism and therefore seldomly monitored, despite their wide and in some cases, long-term use. We report a case of a renal transplant recipient presenting with acute hyperosmolar hyperglycemia after treatment with topical glucocorticoids and present a mini review of the literature. |
| format | Article |
| id | doaj-art-4173e337c2ce43d9a11b777ad089145d |
| institution | Kabale University |
| issn | 2090-651X |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Endocrinology |
| spelling | doaj-art-4173e337c2ce43d9a11b777ad089145d2025-02-03T06:08:39ZengWileyCase Reports in Endocrinology2090-651X2023-01-01202310.1155/2023/3648178Topical Glucocorticoid Use and the Risk of Posttransplant DiabetesSimon Bøtker0Henrik Birn1Lara Aygen Øzbay2Department of NephrologyDepartment of NephrologyDepartment of NephrologySystemically administered glucocorticoids constitute an essential part of the immunosuppressive regimen for transplant recipients, yet their known risks of causing hyperglycemia or posttransplant diabetes require close monitoring and minimisation of use, when possible, to prevent detrimental effects on patient morbidity and graft survival. Topical glucocorticoids, on the other hand, are rarely considered to affect glucose metabolism and therefore seldomly monitored, despite their wide and in some cases, long-term use. We report a case of a renal transplant recipient presenting with acute hyperosmolar hyperglycemia after treatment with topical glucocorticoids and present a mini review of the literature.http://dx.doi.org/10.1155/2023/3648178 |
| spellingShingle | Simon Bøtker Henrik Birn Lara Aygen Øzbay Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes Case Reports in Endocrinology |
| title | Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes |
| title_full | Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes |
| title_fullStr | Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes |
| title_full_unstemmed | Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes |
| title_short | Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes |
| title_sort | topical glucocorticoid use and the risk of posttransplant diabetes |
| url | http://dx.doi.org/10.1155/2023/3648178 |
| work_keys_str_mv | AT simonbøtker topicalglucocorticoiduseandtheriskofposttransplantdiabetes AT henrikbirn topicalglucocorticoiduseandtheriskofposttransplantdiabetes AT laraaygenøzbay topicalglucocorticoiduseandtheriskofposttransplantdiabetes |